+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Porcine Vaccines Market by Indication (Arthritis, Diarrhea, Porcine Circovirus Associated Disease), Technology (Conjugate Vaccines, DNA Vaccines, Inactivated Vaccines), End User - Forecast 2024-2030- Product Image
Global Porcine Vaccines Market by Indication (Arthritis, Diarrhea, Porcine Circovirus Associated Disease), Technology (Conjugate Vaccines, DNA Vaccines, Inactivated Vaccines), End User - Forecast 2024-2030- Product Image
Sale

Global Porcine Vaccines Market by Indication (Arthritis, Diarrhea, Porcine Circovirus Associated Disease), Technology (Conjugate Vaccines, DNA Vaccines, Inactivated Vaccines), End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5715935
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Porcine Vaccines Market size was estimated at USD 1.71 billion in 2023, USD 1.82 billion in 2024, and is expected to grow at a CAGR of 6.72% to reach USD 2.70 billion by 2030.

Porcine vaccines are immunological preparations designed to prevent various swine diseases in pigs. These vaccines are created to stimulate the porcine immune system, enabling it to develop defenses against pathogens such as viruses or bacteria that can cause illness. By mimicking the infection, they prepare the swine’s body to recognize and combat the actual pathogens should they be encountered in the future. The rise in the incidence of swine diseases and the growing global consumption of pork products are major driving factors behind the need for porcine vaccines. Furthermore, supportive government initiatives, including subsidies and awareness programs, have encouraged the use of vaccines.

However, the need for a cold chain infrastructure creates logistical challenges, particularly in developing countries. Furthermore, the variability in the immune response of different pig breeds can impact vaccine effectiveness and create hurdles for the development and adoption of porcine vaccines. However, key players are exploring novel technologies such as nanotechnology, gene editing strategies, and precision medicine to ensure the development of customized vaccines that can overcome the performance challenges of porcine vaccines. Moreover, investigating new adjuvants to enhance immune response without compromising safety and developing needle-free administration could improve vaccine uptake and reduce stress on animals.

Regional Insights

In the Americas region, particularly the U.S. and Canada, the porcine vaccine market is well-established due to the extensive pig farming industry and a strong emphasis on animal health management. The country sees a significant consumer need for vaccinations against prevalent diseases such as porcine reproductive and respiratory syndrome (PRRS), swine influenza, and others. Producers often adopt the latest vaccines, and purchasing behavior indicates a readiness to invest in advanced solutions for swine herds. Recent research in the U.S. has focused on developing vaccines with improved efficacy and longer immunity periods.

Investments in biotechnology companies and government initiatives such as the Veterinary Biologics Program under the United States Department of Agriculture(USDA)-Animal & Plant Health Inspection Service(APHIS) reflect ongoing efforts to strengthen the sector. The EMEA countries represent a diverse market with stringent animal welfare and health regulations. The European consumer requires vaccines that comply with high safety standards, leading to a demand for quality-assured vaccines. The EU’s Horizon 2020 program has seen substantial investments in research addressing swine diseases, which propels the development of new and efficient vaccines. In the APAC region, China represents a highly evolved market for pig meat, thereby accentuating the need for porcine markets. India, with an emerging pig farming industry in the APAC region, presents a moderate but growing demand for porcine vaccines. Consumer needs revolve around affordable and accessible vaccines due to cost-sensitive purchasing behaviors. The government has been encouraging the growth of the swine industry through initiatives that provide support for vaccinations and animal health programs.

Market Trends by Segment

  • Technology: Growing innovations in recombinant vaccines due to advancements in genetic engineering and molecular biology technologies
  • End User: Growing need for mass vaccination programs in the hog/pig production farm

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Zoetis Launches Circomax In The UK

Zoetis has introduced CircoMax to the UK market, a vaccine designed to combat porcine circovirus type 2 (PCV2). This vaccine is formulated to target multiple strains of the virus, offering protection against genotypes PCV2a, PCV2b, and PCV2d. These genotypes represent the primary variants found within the UK’s pig population. The relevance of CircoMax is cemented by current research indicating a shift in the dominant genotypes over time, from PCV2a originally to PCV2b, and most recently to PCV2d, highlighting the dynamic nature of the virus.

Merck Animal Health Launches 3-In-One Swine Vaccine

Merck Animal Health announced the launch of Circumvent CML, a novel trivalent swine vaccine designed to combat key porcine diseases. Circumvent CML marks a significant advancement in swine health, delivering protection against porcine circovirus Type 2a (PCV-2a), porcine circovirus type 2d (PCV-2d), mycoplasma hyopneumoniae, and lawsonia intracellularis in one comprehensive formulation. This innovative vaccine encapsulates the effectiveness of Merck's established antigens and adjuvant systems, previously demonstrated in products such as Circumvent PCV-M G2 and Porcilis Ileitis, providing an integrated solution for swine producers.

Elanco is Exclusive U.S. Distributor of Aptimmune’s PRRS Killed Autogenous Vaccine

Elanco Animal Health Incorporated has secured an exclusive distribution agreement with Aptimmune Biologics, Inc. This arrangement positions Elanco as the sole provider of a novel porcine reproductive and respiratory syndrome (PRRS) vaccine, leveraging Aptimmune's innovative Barricade formula. This inactivated vaccine would complement Elanco's existing Prevacent PRRS live vaccine, thereby enhancing their portfolio of respiratory illness interventions.

Key Company Profiles

The report delves into recent significant developments in the Porcine Vaccines Market, highlighting leading vendors and their innovative profiles. These include Aptimmune Biologics, Inc., Arko Laboratories, AVAC Vietnam Joint Stock Company, Bayer AG, Bimeda Holdings PLC, Biogénesis Bagó S.A., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Eli Lilly and Company, Endovac Animal Health, FATRO S.p.A., Formosa Biomedical Inc., Genvax Technologies, Inc., HIPRA, S.A., Indian Immunologicals Ltd., KM Biologics Co., Ltd., Kyoto Biken Laboratories, Inc., Malaysian Vaccines & Pharmaceuticals Sdn Bhd., Medgene Labs, Merck & Co., Inc., Nisseiken Co., Ltd., PBS Animal Health, Phibro Animal Health Corporation, Virbac SA, Yenher Agro-Products Sdn. Bhd., and Zoetis Inc.

This research report offers invaluable insights into various crucial aspects of the Porcine Vaccines Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in Prevalence of Swine Diseases Worldwide
5.1.1.2. Increasing Demand for High-Quality Pork Meat
5.1.1.3. Government Initiatives to Support Animal Health
5.1.2. Restraints
5.1.2.1. High Cost of Porcine Vaccine Development and Complex Storage Issues
5.1.3. Opportunities
5.1.3.1. Technological Advancements in Porcine Vaccine
5.1.3.2. Favorable Investment Landscape For Production of Novel Porcine Vaccines
5.1.4. Challenges
5.1.4.1. Limited Availability and Awareness Along with Side Effects Associated with Porcine Vaccines
5.2. Market Segmentation Analysis
5.2.1. Technology: Growing innovations in recombinant vaccines due to advancements in genetic engineering and molecular biology technologies
5.2.2. End User: Growing need for mass vaccination programs in the hog/pig production farm
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Porcine Vaccines Market, by Indication
6.1. Introduction
6.2. Arthritis
6.3. Diarrhea
6.4. Porcine Circovirus Associated Disease
6.5. Porcine Reproductive & Respiratory Syndrome
6.6. Swine Influenza
7. Porcine Vaccines Market, by Technology
7.1. Introduction
7.2. Conjugate Vaccines
7.3. DNA Vaccines
7.4. Inactivated Vaccines
7.5. Live attenuated Vaccines
7.6. Recombinant Vaccines
7.7. Toxoid Vaccines
8. Porcine Vaccines Market, by End User
8.1. Introduction
8.2. Hog/Pig Production Farm
8.3. Veterinary Clinics/Hospitals
9. Americas Porcine Vaccines Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Porcine Vaccines Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Porcine Vaccines Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Zoetis Launches Circomax In The UK
12.3.2. Merck Animal Health Launches 3-In-One Swine Vaccine
12.3.3. Elanco is Exclusive U.S. Distributor of Aptimmune’s PRRS Killed Autogenous Vaccine
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. PORCINE VACCINES MARKET RESEARCH PROCESS
FIGURE 2. PORCINE VACCINES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PORCINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PORCINE VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL PORCINE VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PORCINE VACCINES MARKET DYNAMICS
FIGURE 7. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 8. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PORCINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. PORCINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PORCINE VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PORCINE VACCINES MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL PORCINE VACCINES MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL PORCINE VACCINES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL PORCINE VACCINES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL PORCINE VACCINES MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL PORCINE VACCINES MARKET SIZE, BY ARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL PORCINE VACCINES MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL PORCINE VACCINES MARKET SIZE, BY DIARRHEA, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL PORCINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS ASSOCIATED DISEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL PORCINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS ASSOCIATED DISEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL PORCINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL PORCINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL PORCINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL PORCINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL PORCINE VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL PORCINE VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL PORCINE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL PORCINE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL PORCINE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL PORCINE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL PORCINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL PORCINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL PORCINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL PORCINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL PORCINE VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL PORCINE VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL PORCINE VACCINES MARKET SIZE, BY HOG/PIG PRODUCTION FARM, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL PORCINE VACCINES MARKET SIZE, BY HOG/PIG PRODUCTION FARM, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL PORCINE VACCINES MARKET SIZE, BY VETERINARY CLINICS/HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL PORCINE VACCINES MARKET SIZE, BY VETERINARY CLINICS/HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 59. CANADA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 60. CANADA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 61. CANADA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 62. CANADA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 63. CANADA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 64. CANADA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 65. MEXICO PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 66. MEXICO PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 67. MEXICO PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 68. MEXICO PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 69. MEXICO PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 70. MEXICO PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 71. UNITED STATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 72. UNITED STATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 73. UNITED STATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 74. UNITED STATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 75. UNITED STATES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 76. UNITED STATES PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 77. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 78. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 80. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 82. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 84. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 86. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 87. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 88. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 89. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 90. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 91. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 92. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 93. CHINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 94. CHINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 95. CHINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 96. CHINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 97. CHINA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 98. CHINA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 99. INDIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 100. INDIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 101. INDIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 102. INDIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 103. INDIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 104. INDIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 105. INDONESIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 106. INDONESIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 107. INDONESIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 108. INDONESIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 109. INDONESIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 110. INDONESIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 111. JAPAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 112. JAPAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 113. JAPAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 114. JAPAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 115. JAPAN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 116. JAPAN PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 117. MALAYSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 118. MALAYSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 119. MALAYSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 120. MALAYSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 121. MALAYSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 122. MALAYSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 123. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 124. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 125. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 126. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 127. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 128. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 129. SINGAPORE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 130. SINGAPORE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 131. SINGAPORE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 132. SINGAPORE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 133. SINGAPORE PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 134. SINGAPORE PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 135. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 136. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 137. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 138. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 139. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 140. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 141. TAIWAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 142. TAIWAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 143. TAIWAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 144. TAIWAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 145. TAIWAN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 146. TAIWAN PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 147. THAILAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 148. THAILAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 149. THAILAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 150. THAILAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 151. THAILAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 152. THAILAND PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 153. VIETNAM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 154. VIETNAM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 155. VIETNAM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 156. VIETNAM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 157. VIETNAM PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 158. VIETNAM PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 167. DENMARK PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 168. DENMARK PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 169. DENMARK PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 170. DENMARK PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 171. DENMARK PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 172. DENMARK PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 173. EGYPT PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 174. EGYPT PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 175. EGYPT PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 176. EGYPT PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 177. EGYPT PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 178. EGYPT PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 179. FINLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 180. FINLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 181. FINLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 182. FINLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 183. FINLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 184. FINLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 185. FRANCE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 186. FRANCE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 187. FRANCE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 188. FRANCE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 189. FRANCE PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 190. FRANCE PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 191. GERMANY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 192. GERMANY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 193. GERMANY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 194. GERMANY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 195. GERMANY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 196. GERMANY PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 197. ISRAEL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 198. ISRAEL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 199. ISRAEL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 200. ISRAEL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 201. ISRAEL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 202. ISRAEL PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 203. ITALY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 204. ITALY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 205. ITALY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 206. ITALY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 207. ITALY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 208. ITALY PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 209. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 210. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 211. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 212. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 213. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 214. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 215. NIGERIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 216. NIGERIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 217. NIGERIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 218. NIGERIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 219. NIGERIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 220. NIGERIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 221. NORWAY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 222. NORWAY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 223. NORWAY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 224. NORWAY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 225. NORWAY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 226. NORWAY PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 227. POLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 228. POLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 229. POLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 230. POLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 231. POLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 232. POLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 233. QATAR PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 234. QATAR PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 235. QATAR PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 236. QATAR PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 237. QATAR PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 238. QATAR PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 239. RUSSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 240. RUSSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 241. RUSSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 242. RUSSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 243. RUSSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 244. RUSSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 246. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 248. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 250. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 252. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 254. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 256. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 257. SPAIN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 258. SPAIN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 259. SPAIN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 260. SPAIN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 261. SPAIN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 262. SPAIN PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 263. SWEDEN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 264. SWEDEN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 265. SWEDEN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 266. SWEDEN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 267. SWEDEN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 268. SWEDEN PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 269. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 270. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 271. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 272. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 273. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 274. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 275. TURKEY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 276. TURKEY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 277. TURKEY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 278. TURKEY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 279. TURKEY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 280. TURKEY PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 288. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 290. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 292. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 293. PORCINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 294. PORCINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Aptimmune Biologics, Inc.
  • Arko Laboratories
  • AVAC Vietnam Joint Stock Company
  • Bayer AG
  • Bimeda Holdings PLC
  • Biogénesis Bagó S.A.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Eli Lilly and Company
  • Endovac Animal Health
  • FATRO S.p.A.
  • Formosa Biomedical Inc.
  • Genvax Technologies, Inc.
  • HIPRA, S.A.
  • Indian Immunologicals Ltd.
  • KM Biologics Co., Ltd.
  • Kyoto Biken Laboratories, Inc.
  • Malaysian Vaccines & Pharmaceuticals Sdn Bhd.
  • Medgene Labs
  • Merck & Co., Inc.
  • Nisseiken Co., Ltd.
  • PBS Animal Health
  • Phibro Animal Health Corporation
  • Virbac SA
  • Yenher Agro-Products Sdn. Bhd.
  • Zoetis Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.82 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.7 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Porcine Vaccine Global Market Report 2024 - Product Image

Porcine Vaccine Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Porcine Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Global Porcine Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Porcine Vaccine Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Porcine Vaccine Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 110 Pages
  • Global
From
Global Swine Vaccines Market by Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines), Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease), Target Disease - Forecast 2024-2030 - Product Image

Global Swine Vaccines Market by Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines), Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease), Target Disease - Forecast 2024-2030

  • Report
  • 195 Pages
  • Global
From
Swine Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Swine Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 189 Pages
  • Global
From

About the Market

The Swine Vaccine market is a segment of the Animal Pharmaceuticals industry that focuses on the development and production of vaccines for swine. Vaccines are used to protect swine from a variety of diseases, including Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus (PCV), and Classical Swine Fever (CSF). Vaccines are typically administered to swine through injection or oral administration. The Swine Vaccine market is highly competitive, with a number of companies offering a variety of products. Companies in the market include Merck Animal Health, Zoetis, Elanco, Boehringer Ingelheim, and Ceva Sante Animale. These companies offer a range of products, including vaccines for PRRS, PCV, and CSF, as well as other vaccines for swine. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.